{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:00:33Z","timestamp":1789912833132,"version":"4.0.1"},"reference-count":253,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["GM094777"],"award-info":[{"award-number":["GM094777"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA177910"],"award-info":[{"award-number":["CA177910"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.bbcan.2014.10.007","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T08:43:58Z","timestamp":1414831438000},"page":"638-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["mTOR signaling in tumorigenesis"],"prefix":"10.1016","volume":"1846","author":[{"given":"Kai","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengda","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2014.10.007_bb0005","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"Vezina","year":"1975","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0010","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0015","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin\u2013receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1074\/jbc.270.2.815","article-title":"Isolation of a protein target of the FKBP12\u2013rapamycin complex in mammalian cells","volume":"270","author":"Sabers","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cell.2004.06.023","article-title":"Initiating cellular stress responses","volume":"118","author":"Bakkenist","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","article-title":"mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery","volume":"110","author":"Kim","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0060","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1097-2765(03)00114-X","article-title":"GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR","volume":"11","author":"Kim","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0065","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0070","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0075","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.cub.2006.08.001","article-title":"mSin1 is necessary for Akt\/PKB phosphorylation, and its isoforms define three distinct mTORC2s","volume":"16","author":"Frias","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0090","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1","volume":"11","author":"Guertin","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0095","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1101\/gad.1461206","article-title":"Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity","volume":"20","author":"Yang","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0100","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/ncb2860","article-title":"Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis","volume":"15","author":"Liu","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0105","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","article-title":"DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival","volume":"137","author":"Peterson","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncb1547","article-title":"Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40","volume":"9","author":"Vander Haar","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0115","doi-asserted-by":"crossref","first-page":"20036","DOI":"10.1074\/jbc.M702376200","article-title":"PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding","volume":"282","author":"Wang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/BJ20070540","article-title":"Identification of Protor as a novel Rictor-binding component of mTOR complex-2","volume":"405","author":"Pearce","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BJ20102103","article-title":"Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney","volume":"436","author":"Pearce","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm2822","article-title":"The nuts and bolts of AGC protein kinases","volume":"11","author":"Pearce","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0135","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0145","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: one hallmark, many faces","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0150","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/34432","article-title":"A serine\/threonine kinase gene defective in Peutz\u2013Jeghers syndrome","volume":"391","author":"Hemminki","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0160","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0165","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI44145","article-title":"Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy","volume":"121","author":"Wander","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0170","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1200\/JCO.2008.20.0766","article-title":"Targeting the mTOR signaling network for cancer therapy","volume":"27","author":"Meric-Bernstam","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0175","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1128\/MCB.24.15.6710-6718.2004","article-title":"mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells","volume":"24","author":"Murakami","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0180","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1128\/MCB.24.21.9508-9516.2004","article-title":"Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development","volume":"24","author":"Gangloff","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0185","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.celrep.2013.07.030","article-title":"Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression","volume":"4","author":"Wu","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0190","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1083\/jcb.200903131","article-title":"Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy","volume":"187","author":"Risson","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2008.09.003","article-title":"Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration","volume":"8","author":"Polak","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0200","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","article-title":"Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy","volume":"8","author":"Bentzinger","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0205","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.110.977066","article-title":"Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice","volume":"123","author":"Shende","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0210","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1523\/JNEUROSCI.3294-12.2013","article-title":"Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis","volume":"33","author":"Cloetta","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0215","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nature09584","article-title":"mTORC1 controls fasting-induced ketogenesis and its modulation by ageing","volume":"468","author":"Sengupta","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0220","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1172\/JCI62279","article-title":"mTORC1 is essential for leukemia propagation but not stem cell self-renewal","volume":"122","author":"Hoshii","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0225","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.devcel.2006.08.013","article-title":"Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability","volume":"11","author":"Shiota","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0230","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/MCB.01405-07","article-title":"Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity","volume":"28","author":"Kumar","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0235","doi-asserted-by":"crossref","first-page":"29579","DOI":"10.1074\/jbc.M112.386854","article-title":"Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2","volume":"287","author":"Yuan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0240","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/db09-1061","article-title":"Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism","volume":"59","author":"Kumar","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0245","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/hmg\/dds414","article-title":"Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex","volume":"22","author":"Carson","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0250","doi-asserted-by":"crossref","first-page":"e1000393","DOI":"10.1371\/journal.pbio.1000393","article-title":"Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice","volume":"8","author":"Siuta","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0255","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/acel.12256","article-title":"Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan","volume":"13","author":"Lamming","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2008.12.017","article-title":"mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice","volume":"15","author":"Guertin","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.molcel.2010.07.031","article-title":"Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells","volume":"39","author":"Lazorchak","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0270","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/eji.201142066","article-title":"Sin1 regulates Treg-cell development but is not required for T-cell growth and proliferation","volume":"42","author":"Chang","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0275","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0280","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1\u2013TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0285","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0295","doi-asserted-by":"crossref","first-page":"13489","DOI":"10.1073\/pnas.0405659101","article-title":"Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase","volume":"101","author":"Roux","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0300","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","article-title":"Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome","volume":"156","author":"Menon","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0305","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0310","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1207056","article-title":"mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase","volume":"334","author":"Zoncu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0315","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cell.2014.01.024","article-title":"Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2","volume":"156","author":"Demetriades","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0320","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1470-2045(07)70411-4","article-title":"Possible mechanisms of disease development in tuberous sclerosis","volume":"9","author":"Jozwiak","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0325","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1073\/pnas.151033798","article-title":"A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice","volume":"98","author":"Kobayashi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0330","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0335","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/hmg\/ddi190","article-title":"A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma","volume":"14","author":"Wilson","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0340","doi-asserted-by":"crossref","first-page":"8937","DOI":"10.1158\/0008-5472.CAN-10-1646","article-title":"Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice","volume":"70","author":"Kladney","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0345","doi-asserted-by":"crossref","first-page":"ra24","DOI":"10.1126\/scisignal.2002739","article-title":"Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice","volume":"5","author":"Menon","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0350","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1074\/jbc.M113.526335","article-title":"Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling","volume":"289","author":"Chen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0355","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/j.gastro.2013.01.053","article-title":"Akt and mTORC1 have different roles during liver tumorigenesis in mice","volume":"144","author":"Kenerson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0360","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1210\/me.2013-1059","article-title":"Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs","volume":"27","author":"Prizant","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0365","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2353\/ajpath.2009.080055","article-title":"PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL\/6 mice via mTOR-dependent growth","volume":"174","author":"Blando","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0370","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/ncb996","article-title":"Rheb promotes cell growth as a component of the insulin\/TOR signalling network","volume":"5","author":"Saucedo","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0375","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ncb995","article-title":"Rheb is an essential regulator of S6K in controlling cell growth in Drosophila","volume":"5","author":"Stocker","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0380","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb","volume":"13","author":"Tee","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0385","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.201306041","article-title":"Where is mTOR and what is it doing there?","volume":"203","author":"Betz","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0390","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/498444a","article-title":"Cell signalling: nutrient sensing lost in cancer","volume":"498","author":"Menon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0395","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/MCB.00985-10","article-title":"Rheb is essential for murine development","volume":"31","author":"Goorden","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.devcel.2010.11.020","article-title":"Rheb1 is required for mTORC1 and myelination in postnatal brain development","volume":"20","author":"Zou","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0405","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cmet.2013.03.014","article-title":"Rheb regulates mitophagy induced by mitochondrial energetic status","volume":"17","author":"Melser","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0410","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1101\/gad.1690808","article-title":"Tumorigenic activity and therapeutic inhibition of Rheb GTPase","volume":"22","author":"Mavrakis","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0415","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.1699608","article-title":"Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events","volume":"22","author":"Nardella","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0420","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1158\/0008-5472.CAN-09-3467","article-title":"Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis","volume":"70","author":"Lu","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0425","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1074\/jbc.M004389200","article-title":"Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B","volume":"276","author":"Sekiguchi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0430","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/ncb1753","article-title":"Regulation of TORC1 by Rag GTPases in nutrient response","volume":"10","author":"Kim","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0435","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","article-title":"The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1","volume":"320","author":"Sancak","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0440","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nature11745","article-title":"Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival","volume":"493","author":"Efeyan","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0445","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.devcel.2014.03.017","article-title":"RagA, but not RagB, is essential for embryonic development and adult mice","volume":"29","author":"Efeyan","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0450","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1038\/ncomms5241","article-title":"Rag GTPases are cardioprotective by regulating lysosomal function","volume":"5","author":"Kim","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0455","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.molcel.2013.09.016","article-title":"The folliculin tumor suppressor is a GAP for the RagC\/D GTPases that signal amino acid levels to mTORC1","volume":"52","author":"Tsun","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0460","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.1232044","article-title":"A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1","volume":"340","author":"Bar-Peled","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0465","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1741-7007-11-36","article-title":"LKB1 and AMPK and the cancer-metabolism link \u2014 ten years after","volume":"11","author":"Hardie","year":"2013","journal-title":"BMC Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0470","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0475","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy","volume":"8","author":"Hardie","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0480","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0485","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2741\/3229","article-title":"AMPK: lessons from transgenic and knockout animals","volume":"14","author":"Viollet","year":"2009","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0490","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1096\/fj.10-155994","article-title":"Coordinated maintenance of muscle cell size control by AMP-activated protein kinase","volume":"24","author":"Lantier","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0495","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI16567","article-title":"The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity","volume":"111","author":"Viollet","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0500","doi-asserted-by":"crossref","first-page":"12187","DOI":"10.1074\/jbc.M112.430389","article-title":"Genetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice","volume":"288","author":"Kang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0505","doi-asserted-by":"crossref","first-page":"38441","DOI":"10.1074\/jbc.M405533200","article-title":"The 5\u2032-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle","volume":"279","author":"Barnes","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0510","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1073\/pnas.1105062108","article-title":"AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise","volume":"108","author":"O'Neill","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0515","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0520","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0525","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","article-title":"AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo","volume":"17","author":"Faubert","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0530","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1947601912452883","article-title":"AMPKalpha2 suppresses murine embryonic fibroblast transformation and tumorigenesis","volume":"3","author":"Phoenix","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0535","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature11066","article-title":"AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress","volume":"485","author":"Jeon","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0540","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","article-title":"A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells","volume":"11","author":"Kwiatkowski","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0545","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4161\/auto.25722","article-title":"MTORC1 determines autophagy through ULK1 regulation in skeletal muscle","volume":"9","author":"Castets","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0550","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1172\/JCI69780","article-title":"iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions","volume":"124","author":"Wu","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0555","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/hmg\/ddq570","article-title":"Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin","volume":"20","author":"Malhowski","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0560","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cmet.2009.03.005","article-title":"Critical role for hypothalamic mTOR activity in energy balance","volume":"9","author":"Mori","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0565","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0570","first-page":"1206","article-title":"Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice","volume":"59","author":"Kobayashi","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0575","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1093\/hmg\/dds262","article-title":"Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features","volume":"21","author":"Yuan","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0580","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1210\/en.2011-1911","article-title":"Inactivation of AMPKalpha1 induces asthenozoospermia and alters spermatozoa morphology","volume":"153","author":"Tartarin","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0585","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1074\/jbc.M109.056762","article-title":"AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance","volume":"285","author":"Dzamko","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0590","doi-asserted-by":"crossref","first-page":"37198","DOI":"10.1074\/jbc.M110.102434","article-title":"Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity","volume":"285","author":"Steinberg","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0595","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1096\/fj.13-238972","article-title":"Muscle-specific AMPK beta1beta2-null mice display a myopathy due to loss of capillary density in nonpostural muscles","volume":"28","author":"Thomas","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0600","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Ma","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0605","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0610","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nature13492","article-title":"Coordinated regulation of protein synthesis and degradation by mTORC1","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0615","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature03205","article-title":"Regulation of cap-dependent translation by eIF4E inhibitory proteins","volume":"433","author":"Richter","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0620","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/sj.onc.1207549","article-title":"eIF4E \u2014 from translation to transformation","volume":"23","author":"Mamane","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0625","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm1001-1128","article-title":"Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1","volume":"7","author":"Tsukiyama-Kohara","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0630","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1172\/JCI29528","article-title":"Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2","volume":"117","author":"Le Bacquer","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0635","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1111\/j.1365-2567.2008.02981.x","article-title":"Impaired myelopoiesis in mice lacking the repressors of translation initiation, 4E-BP1 and 4E-BP2","volume":"128","author":"Olson","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0640","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0645","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccr.2009.09.025","article-title":"p53-dependent translational control of senescence and transformation via 4E-BPs","volume":"16","author":"Petroulakis","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0650","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2010.05.023","article-title":"4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors","volume":"18","author":"She","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0655","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1128\/MCB.11.11.5541","article-title":"Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini","volume":"11","author":"Grove","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0660","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1073\/pnas.89.9.4052","article-title":"A single gene encodes two isoforms of the p70 S6 kinase: activation upon mitogenic stimulation","volume":"89","author":"Reinhard","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0665","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1093\/emboj\/17.22.6649","article-title":"Disruption of the p70(s6k)\/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase","volume":"17","author":"Shima","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0670","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/MCB.24.8.3112-3124.2004","article-title":"S6K1(\u2212\/\u2212)\/S6K2(\u2212\/\u2212) mice exhibit perinatal lethality and rapamycin-sensitive 5\u2032-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway","volume":"24","author":"Pende","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0675","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/35050135","article-title":"Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice","volume":"408","author":"Pende","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0680","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","article-title":"Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity","volume":"431","author":"Um","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0685","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","article-title":"Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1","volume":"3","author":"Um","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0690","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.1199498","article-title":"The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling","volume":"332","author":"Hsu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0695","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.1199484","article-title":"Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling","volume":"332","author":"Yu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0700","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004754","article-title":"Regulation of cholesterol and fatty acid synthesis","volume":"3","author":"Ye","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0705","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0710","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2012.09.002","article-title":"Expanding roles for SREBP in metabolism","volume":"16","author":"Shao","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0715","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0720","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0725","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1172\/JCI119746","article-title":"Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene","volume":"100","author":"Shimano","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0730","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1074\/jbc.M111421200","article-title":"Diminished hepatic response to fasting\/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c","volume":"277","author":"Liang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0735","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI118951","article-title":"Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a","volume":"98","author":"Shimano","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0740","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI119248","article-title":"Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells","volume":"99","author":"Shimano","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0745","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0750","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","article-title":"Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway","volume":"148","author":"Freed-Pastor","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0755","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1083\/jcb.56.3.746","article-title":"A morphometric study of the removal of phenobarbital-induced membranes from hepatocytes after cessation of threatment","volume":"56","author":"Bolender","year":"1973","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0760","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrm3522","article-title":"Amino acid signalling upstream of mTOR","volume":"14","author":"Jewell","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0765","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ncb0910-814","article-title":"Eaten alive: a history of macroautophagy","volume":"12","author":"Yang","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0770","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.cub.2010.04.041","article-title":"DAP1, a novel substrate of mTOR, negatively regulates autophagy","volume":"20","author":"Koren","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0775","doi-asserted-by":"crossref","first-page":"903","DOI":"10.4161\/auto.19653","article-title":"MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB","volume":"8","author":"Martina","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0780","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1242\/dev.125.23.4607","article-title":"The bHLH-Zip transcription factor Tfeb is essential for placental vascularization","volume":"125","author":"Steingrimsson","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0785","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood-2008-02-137398","article-title":"Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation","volume":"112","author":"Kundu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0790","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI20039","article-title":"Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene","volume":"112","author":"Qu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0795","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1172\/JCI28833","article-title":"Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma","volume":"117","author":"Amaravadi","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0800","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0805","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1101\/gad.213827.113","article-title":"A RANKL-PKCbeta-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts","volume":"27","author":"Ferron","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0810","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0815","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.08.008","article-title":"The Akt-mTOR tango and its relevance to cancer","volume":"8","author":"Hay","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0820","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1158\/0008-5472.CAN-06-0743","article-title":"Akt signaling and cancer: surviving but not moving on","volume":"66","author":"Toker","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0825","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1006\/bbrc.1995.2654","article-title":"Molecular cloning and characterization of a new member of the RAC protein kinase family: association of the pleckstrin homology domain of three types of RAC protein kinase with protein kinase C subspecies and beta gamma subunits of G proteins","volume":"216","author":"Konishi","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0830","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1242\/jcs.02724","article-title":"Protein kinase B\/Akt at a glance","volume":"118","author":"Fayard","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0835","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.advenzreg.2011.09.020","article-title":"Achieving specificity in Akt signaling in cancer","volume":"52","author":"Toker","year":"2012","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0840","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0845","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0850","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4161\/cc.8.16.9335","article-title":"The Akt kinases: isoform specificity in metabolism and cancer","volume":"8","author":"Gonzalez","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0855","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0860","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature13079","article-title":"Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus","volume":"508","author":"Liu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0865","doi-asserted-by":"crossref","first-page":"38349","DOI":"10.1074\/jbc.C100462200","article-title":"Akt1\/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice","volume":"276","author":"Cho","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0870","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","article-title":"Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)","volume":"292","author":"Cho","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0875","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/MCB.25.5.1869-1878.2005","article-title":"Role for Akt3\/protein kinase Bgamma in attainment of normal brain size","volume":"25","author":"Easton","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0880","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1101\/gad.913901","article-title":"Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene","volume":"15","author":"Chen","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0885","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI16885","article-title":"Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2\/PKB beta","volume":"112","author":"Garofalo","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0890","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1242\/dev.01864","article-title":"Essential role of protein kinase B gamma (PKB gamma\/Akt3) in postnatal brain development but not in glucose homeostasis","volume":"132","author":"Tschopp","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0895","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/MCB.25.23.10407-10418.2005","article-title":"Dosage-dependent effects of Akt1\/protein kinase Balpha (PKBalpha) and Akt3\/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice","volume":"25","author":"Yang","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0900","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1101\/gad.1089403","article-title":"Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2","volume":"17","author":"Peng","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0905","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1128\/MCB.00722-06","article-title":"Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies","volume":"26","author":"Dummler","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0910","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0915","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1158\/0008-5472.CAN-04-2933","article-title":"Mutation of the PIK3CA gene in ovarian and breast cancer","volume":"64","author":"Campbell","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0920","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Samuels","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0925","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.onc.1208304","article-title":"PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas","volume":"24","author":"Lee","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0930","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1158\/1078-0432.CCR-04-2142","article-title":"Frequent mutation of the PIK3CA gene in ovarian and breast cancers","volume":"11","author":"Levine","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0935","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0940","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature11154","article-title":"Sequence analysis of mutations and translocations across breast cancer subtypes","volume":"486","author":"Banerji","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0945","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1158\/0008-5472.CAN-06-3782","article-title":"Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2\/neu and MMTV-polyoma middle T transgenic mice","volume":"67","author":"Maroulakou","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0950","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-08-4287","article-title":"Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression","volume":"69","author":"Dillon","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0955","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1242\/jcs.00982","article-title":"PKC at a glance","volume":"117","author":"Parker","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0960","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00125-009-1278-y","article-title":"Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice","volume":"52","author":"Meier","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0965","doi-asserted-by":"crossref","first-page":"11114","DOI":"10.1073\/pnas.191369098","article-title":"Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC","volume":"98","author":"Chen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.10.007_bb0970","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.2337\/diabetes.53.8.2101","article-title":"Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice","volume":"53","author":"Menne","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0975","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1126\/science.273.5276.788","article-title":"Immunodeficiency in protein kinase cbeta-deficient mice","volume":"273","author":"Leitges","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0980","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0092-8674(93)90613-U","article-title":"Modified hippocampal long-term potentiation in PKC gamma-mutant mice","volume":"75","author":"Abeliovich","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0985","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0092-8674(93)90614-V","article-title":"PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning","volume":"75","author":"Abeliovich","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0990","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/416860a","article-title":"Protein kinase Cdelta controls self-antigen-induced B-cell tolerance","volume":"416","author":"Mecklenbrauker","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb0995","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/416865a","article-title":"Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta","volume":"416","author":"Miyamoto","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1000","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0896-6273(00)80837-5","article-title":"A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice","volume":"24","author":"Khasar","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.194.9.1231","article-title":"Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection","volume":"194","author":"Castrillo","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1010","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1097-2765(01)00361-6","article-title":"Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway","volume":"8","author":"Leitges","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1015","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1093\/emboj\/cdf407","article-title":"Role of zeta PKC in B-cell signaling and function","volume":"21","author":"Martin","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1020","first-page":"237","article-title":"Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples","volume":"15","author":"Sharif","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1083\/jcb.200311011","article-title":"Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo","volume":"164","author":"Murray","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1030","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1158\/0008-5472.CAN-05-3405","article-title":"A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells","volume":"66","author":"Stallings-Mann","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1035","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-06-2366","article-title":"Amplification of MDS1\/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer","volume":"67","author":"Nanjundan","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1040","doi-asserted-by":"crossref","first-page":"45556","DOI":"10.1074\/jbc.M407701200","article-title":"Protein kinase CbetaII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo","volume":"279","author":"Liu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1045","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1053\/j.seminoncol.2006.03.019","article-title":"Protein kinase C-beta as a therapeutic target in breast cancer","volume":"33","author":"Sledge","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1050","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrd3871","article-title":"Protein kinase C, an elusive therapeutic target?","volume":"11","author":"Mochly-Rosen","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1055","doi-asserted-by":"crossref","first-page":"18644","DOI":"10.1016\/S0021-9258(19)37009-7","article-title":"Accelerated proliferation and interleukin-2 production of thymocytes by stimulation of soluble anti-CD3 monoclonal antibody in transgenic mice carrying a rabbit protein kinase C alpha","volume":"267","author":"Iwamoto","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tips.2009.10.006","article-title":"Protein kinase Calpha: disease regulator and therapeutic target","volume":"31","author":"Konopatskaya","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/iub.209","article-title":"Relative resistance of SGK1 knockout mice against chemical carcinogenesis","volume":"61","author":"Nasir","year":"2009","journal-title":"IUBMB Life"},{"issue":"Pt 1","key":"10.1016\/j.bbcan.2014.10.007_bb1070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/0264-6021:3440189","article-title":"Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase","volume":"344","author":"Kobayashi","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1075","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1152\/physrev.00050.2005","article-title":"(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms","volume":"86","author":"Lang","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1080","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI0215696","article-title":"Impaired renal Na(+) retention in the sgk1-knockout mouse","volume":"110","author":"Wulff","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1085","doi-asserted-by":"crossref","first-page":"R945","DOI":"10.1152\/ajpregu.00484.2005","article-title":"Renal function of gene-targeted mice lacking both SGK1 and SGK3","volume":"290","author":"Grahammer","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000276561","article-title":"SGK1-dependent intestinal tumor growth in APC-deficient mice","volume":"25","author":"Wang","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1159\/000354486","article-title":"Inhibition of colonic tumor growth by the selective SGK inhibitor EMD638683","volume":"32","author":"Towhid","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/08977194.2010.518616","article-title":"Second AKT: the rise of SGK in cancer signalling","volume":"28","author":"Bruhn","year":"2010","journal-title":"Growth Factors"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2009.04.012","article-title":"AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer","volume":"16","author":"Vasudevan","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/pros.21416","article-title":"Serum\/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers","volume":"72","author":"Szmulewitz","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1115","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1756-9966-31-4","article-title":"Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas","volume":"31","author":"Abbruzzese","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1120","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/molehr\/8.5.426","article-title":"FSH-regulated gene expression profiles in ovarian tumours and normal ovaries","volume":"8","author":"Chu","year":"2002","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1125","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1016-8478(23)15119-3","article-title":"Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray","volume":"14","author":"Chung","year":"2002","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1130","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1158\/0008-5472.CAN-03-3465","article-title":"Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion","volume":"64","author":"Hutchinson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1135","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI200422230","article-title":"PKC-theta knockout mice are protected from fat-induced insulin resistance","volume":"114","author":"Kim","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/35006090","article-title":"PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes","volume":"404","author":"Sun","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1145","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/cr.2007.64","article-title":"Expanding mTOR signaling","volume":"17","author":"Yang","year":"2007","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1150","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1158\/2159-8290.CD-13-0063","article-title":"What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway","volume":"3","author":"Klempner","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1155","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1160","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1165","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2008.245","article-title":"PI3K pathway alterations in cancer: variations on a theme","volume":"27","author":"Yuan","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1175","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cub.2005.02.053","article-title":"Rheb binds and regulates the mTOR kinase","volume":"15","author":"Long","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1180","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.1073\/pnas.0712268105","article-title":"Phospholipase D1 is an effector of Rheb in the mTOR pathway","volume":"105","author":"Sun","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1185","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1128\/MCB.00782-08","article-title":"Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin","volume":"29","author":"Toschi","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1190","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.0308061100","article-title":"The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress","volume":"101","author":"Shaw","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1195","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1073\/pnas.0908853106","article-title":"Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2","volume":"106","author":"Hasumi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1200","doi-asserted-by":"crossref","first-page":"ra68","DOI":"10.1126\/scisignal.2005103","article-title":"REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling","volume":"7","author":"Dennis","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1205","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","article-title":"Targeting the PI3K-Akt pathway in human cancer: rationale and promise","volume":"4","author":"Luo","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1210","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1215","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1172\/JCI67674","article-title":"Rapamycin extends murine lifespan but has limited effects on aging","volume":"123","author":"Neff","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ccr.2006.07.003","article-title":"Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin","volume":"10","author":"Phung","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1230","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial","volume":"372","author":"Motzer","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1235","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1038\/cddis.2013.506","article-title":"TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists","volume":"4","author":"Blagosklonny","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1240","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/ijc.28579","article-title":"Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts","volume":"134","author":"Ingels","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.10.007_bb1245","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","article-title":"AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity","volume":"70","author":"Chresta","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1250","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.bmcl.2013.01.019","article-title":"Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014","volume":"23","author":"Pike","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.01.005","article-title":"mTOR inhibitors in cancer therapy","volume":"319","author":"Zaytseva","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1260","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.2951","article-title":"Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing","volume":"32","author":"Heckl","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbcan.2014.10.007_bb1265","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/nm.2941","article-title":"Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma","volume":"18","author":"Kwong","year":"2012","journal-title":"Nat. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X14000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X14000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T12:19:40Z","timestamp":1717503580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X14000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":253,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0304419X14000973"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2014.10.007","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mTOR signaling in tumorigenesis","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2014.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}